Saluda Medical Inc
ASX:SLD
Prices of ASX stocks are not being updated. The latest SLD price on Alpha Spread is from Oct 14, 2026. Financials, forecasts and intrinsic value keep updating.
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
S
|
Saluda Medical Inc
ASX:SLD
|
US |
|
ENvue Medical Inc
OTC:FEED
|
US |
|
Menicon Co Ltd
F:5FR
|
JP |
|
Mustika Ratu Tbk PT
IDX:MRAT
|
ID |
|
B
|
Baker Hughes Co
F:68V
|
US |
|
T
|
Tooru PLC
F:73N
|
UK |
Intrinsic Value
There is not enough data to reliably calculate the intrinsic value for Saluda Medical Inc.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Saluda Medical Does
Saluda Medical, Inc. is a commercial-stage medical device company. The company is headquartered in Bloomington, Minnesota. The company went IPO on 2025-12-05. The Company’s closed-loop, dose-control platform is designed to sense and measure neural responses to stimulation and automatically adjust therapy based on real-time neurophysiological feedback. The company is focused on leveraging its platform to disrupt and grow the spinal cord stimulation (SCS) market for chronic pain.
- Headquarters
- United States of America US
- IPO date
- Dec 5, 2025
